Bristol-Myers Squibb (BMY) has an average rating of overweight and mean price target of $64.61, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $64.18, Change: $-0.68, Percent Change: -1.05%